Table 1.
CF patients | Number of sequential isolates with () or without () O-antigen | O-antigen profiles (in Figure 2) | Isolate ribo-patterns (R)/RAPD profiles | Patient clinical outcome | Duration of the chronic infection with the Bcc strain (years) |
---|---|---|---|---|---|
Burkholderia cenocepacia IIIA | |||||
I | 3 | A1 | R08/RAPD01 | Infection eradicated | 2.6 |
J | 1 10 | A2 and A3 | R11/RAPD02 | Dead * | 3.4 |
O | 10 | A4 | R11/RAPD03 | Infection eradicated before death | 3 |
P | 3 | A5 | R13/RAPD04 | Infection eradicated before death | 2.5 |
AB | 17 29 | A6 and A7 | R07/RAPD05 | Still infected | 14.7 |
AF | 2 5 1 | A8 and A10 A9 | ND/RAPD06 RAPD07 | Dead | 2.5 0.1 |
AN | 10 21 | A11 and A12 | R21/RAPD08 | Dead | 6.8 |
Burkholderia cenocepacia IIIB | |||||
O |
8 2 |
B1 B2 | R14/RAPD09 RAPD10 | Infection eradicated before death | 3.4 0.7 |
R | 12 2 11 | B3 and B4 | R15/RAPD10 | Infection eradicated | 7.5 |
T | 6 | B5 | R16/RAPD11 | Infection eradicated before death | 1.2 |
Burkholderia cepacia | |||||
D | 11 | C1 | ND/RAPD12 | Dead | 4.4 |
N | 28 | C2 | R12 | Dead | 3.8 |
O | 24 | C2 | R12 | Infection eradicated before death | 5.6 |
AL | 10 | C1 | R19/RAPD12 | Infection eradicated | 2.2 |
AP | 5 | C1 | R19 | Infection eradicated | 2.8 |
AQ | 10 | C5 | R24 | Infection eradicated | 2.9 |
AU |
32 2 |
C3 C4 | ND/RAPD12 RAPD13 | Still infected | 9.6 0.4 |
Burkholderia contaminans | |||||
V | 13 | D1 | R17 | Alive | 15.2 |
AF | 29 | D2 | R02 | Dead | 5.8 |
Burkholderia multivorans | |||||
J | 2 6 1 | E1 and E2 | R9 | Dead* | 4 |
Burkholderia dolosa | |||||
AR | 14 | F | ND | Dead | 5.5 |
Burkholderia stabilis | |||||
B |
4 1 |
G1 G2 | R01/RAPD15 RAPD14 | Dead | 3.8 0.1 |
H |
8 4 |
G3 G4 | R01/RAPD14 RAPD15 | Dead* | 2.5 2 |
Information on the number of sequential clonal isolates in which the OAg is present () or absent () and the corresponding OAg profiles (Figure 2), when present, the ripopatterns of the isolates (Cunha et al., 2003, 2007; Coutinho et al., 2015) and their RAPD profiles (Figure S1) and the duration of the chronic infection and clinical outcome of the infected CF patients (Cunha et al., 2003, 2007; Coutinho et al., 2011; Moreira et al., 2014) is provided. R, Isolate ribopattern; RAPD, Random amplified polymorphism DNA profile (Figure S1); ND, not determined;
, cepacia syndrome.